Skip to main content
MedPath Trial logoMedPath TrialMedPath Trial Home
Clinical Trials/NCT07142005
NCT07142005RecruitingNot Applicable

Cultural Adaptation of an Educational Tool in Medullary Thyroid Cancer

M.D. Anderson Cancer Center3 sites in 1 country40 target enrollmentStarted: August 15, 2025Last updated:
Share to TwitterShare to FacebookShare to LinkedInShare to Reddit
Conditions

Trial Snapshot

Phase
Not Applicable
Status
Recruiting
Enrollment
40
Locations
3
Primary Endpoint
Questionnaires/Survey Measures
Study OverviewStudy DesignEligibility CriteriaOutcomesInvestigatorsSitesRecords & IdentifiersSimilar Trials

Study Overview

Brief Summary

To find good information about medullary thyroid cancer that is easy to understand and reliable, so researchers aim to design some new educational materials to help.

Detailed Description

Primary Objectives

  1. To co-develop a culturally-adapted educational tool for the Latino/Latina MTC population using the previously developed MTCEducate.org as a framework. (Phase 1)
  2. To test, refine, and produce a culturally adapted educational prototype and is intended to assess participants' understanding after reviewing the decision aid as part of the iterative testing and refinement process (Phase 2)

Secondary Objectives

  1. To assess the tool's acceptability post-production among a broader population of Latino(a) MTC participants and caregivers using the Ottawa Acceptability Scale (Phase 3)
  2. To disseminate the educational tool to a broader population of Latino(a)s
  3. To summarize the clinico-demographics of educational tool users

Study Design

Study Type
Observational
Observational Model
Cohort
Time Perspective
Prospective

Eligibility Criteria

Ages
18 Years to — (Adult, Older Adult)
Sex
All
Accepts Healthy Volunteers
No

Inclusion Criteria

  • •Provision of signed and dated informed consent form
  • •Males and females; Age: ≥18 years old
  • •Identified ethnicity as "Hispanic" or "Latino/Latina"
  • •Ability to read, write, and speak Spanish
  • •Those who are pregnant are eligible to participate
  • •Have or will face this decision, including: a. Participant/survivor - who has medullary thyroid carcinoma, as determined by a clinician or documented in Multi-Institutional Medullary Thyroid Cancer Collaborative Registry; b. Caregiver/family member - of Participant/survivor who has medullary thyroid carcinoma, as nominated by the Participant/survivor

Exclusion Criteria

  • •Those < age 18
  • •Ethnic identity as non-Hispanic or non-Latino/a individual
  • •Individuals with cognitive or psychological impairment (e.g., depression, anxiety, severe mental illness as documented in the registry

Outcomes

Primary Outcomes

Questionnaires/Survey Measures

Time Frame: Through study completion; an average of 1 year

Secondary Outcomes

No secondary outcomes reported

Investigators

Sponsor Class
Other
Responsible Party
Sponsor

Study Sites (3)

Loading locations...

Similar Trials

Completed
Not Applicable
Evaluation of an Education Program to Increase Knowledge and Participation in Clinical Trials Among Racial/Ethnic and Rural PopulationsMalignant Solid NeoplasmHematopoietic and Lymphoid System Neoplasm
NCT06112002Ohio State University Comprehensive Cancer Center78
Completed
Phase 3
An Efficacy Study Comparing ZD6474 to Placebo in Medullary Thyroid CancerThyroid Cancer
NCT00410761Genzyme, a Sanofi Company331
Completed
Not Applicable
Mobile Health (mHealth) Black Women With Breast CancerBreast Neoplasms
NCT02463474University of Florida6
Completed
Not Applicable
Understanding COVID-19 Testing Knowledge and Practices Among 2-1-1 Helpline CallersHealth Knowledge, Attitudes, PracticeCommunication
NCT05812599Washington University School of Medicine298
Completed
Not Applicable
Improving Colorectal Cancer Screening for Diverse Hispanics in Urban Primary CareColorectal Cancer Screening
NCT01569620Icahn School of Medicine at Mount Sinai386